You can buy or sell TRIL and other stocks, options, ETFs, and crypto commission-free!
Trillium Therapeutics Inc. Common Shares, also called Trillium Therapeutics, is a clinical stage immuno-oncology company, which engages in the research and development of therapies for the treatment of cancer. Read More Its pipeline is comprised of TTI-621, TTI-622, and TTI-10001 (Sting Agonist). The company was founded on March 31, 2004 and is headquartered in Mississauga, Canada.
52 Week High
52 Week Low
— per share
Expected May 27, Pre-Market